Mutual of America Capital Management LLC Has $4.67 Million Holdings in Envista Holdings Co. (NYSE:NVST)

Mutual of America Capital Management LLC increased its stake in Envista Holdings Co. (NYSE:NVST) by 27.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 194,055 shares of the company’s stock after purchasing an additional 41,284 shares during the period. Mutual of America Capital Management LLC’s holdings in Envista were worth $4,669,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Eagle Bay Advisors LLC acquired a new position in shares of Envista during the 2nd quarter worth about $35,000. Belpointe Asset Management LLC boosted its stake in shares of Envista by 80.6% during the 1st quarter. Belpointe Asset Management LLC now owns 901 shares of the company’s stock worth $37,000 after buying an additional 402 shares during the last quarter. Headinvest LLC acquired a new position in shares of Envista during the 3rd quarter worth about $28,000. Fifth Third Bancorp boosted its stake in shares of Envista by 98.1% during the 4th quarter. Fifth Third Bancorp now owns 1,254 shares of the company’s stock worth $30,000 after buying an additional 621 shares during the last quarter. Finally, Covestor Ltd lifted its stake in Envista by 35.0% in the 1st quarter. Covestor Ltd now owns 1,273 shares of the company’s stock valued at $62,000 after purchasing an additional 330 shares during the last quarter.

Wall Street Analyst Weigh In

NVST has been the subject of several recent analyst reports. SVB Leerink initiated coverage on shares of Envista in a research note on Monday, February 26th. They issued an “underperform” rating and a $19.00 target price for the company. TheStreet downgraded shares of Envista from a “c” rating to a “d+” rating in a research note on Wednesday, February 7th. UBS Group initiated coverage on shares of Envista in a research note on Friday, January 5th. They issued a “neutral” rating and a $26.00 target price for the company. William Blair downgraded shares of Envista from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 8th. Finally, Jefferies Financial Group downgraded shares of Envista from a “buy” rating to a “hold” rating and cut their target price for the company from $30.00 to $23.00 in a research note on Friday, February 9th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $29.60.

Envista Price Performance

Envista stock opened at $19.16 on Tuesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.23 and a quick ratio of 1.90. Envista Holdings Co. has a twelve month low of $18.95 and a twelve month high of $39.28. The company’s 50-day moving average price is $21.45 and its two-hundred day moving average price is $23.09.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, February 7th. The company reported $0.29 EPS for the quarter, missing the consensus estimate of $0.33 by ($0.04). Envista had a positive return on equity of 6.31% and a negative net margin of 3.90%. The business had revenue of $645.60 million for the quarter, compared to the consensus estimate of $638.37 million. During the same period in the prior year, the business posted $0.52 earnings per share. The firm’s revenue for the quarter was down 2.3% compared to the same quarter last year. On average, equities research analysts predict that Envista Holdings Co. will post 1.43 EPS for the current year.

Envista Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.